PacificHealth Laboratories Announces Receipt of Patent for Their Accelerade(R) Sports Drink

PacificHealth Laboratories Announces Receipt of Patent for Their Accelerade(R) Sports Drink Company announces that the U. S. Patent and Trademark Office issued patent number US 6,989,171 for the use of carbohydrate and protein in combination for a sports drink.
Home Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P. Natrol Appoints Vincent Andrich VP Sales for Prolab Division Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results Body Shop Reports 24.8 Mil Euro Sales Revenues Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label Supplement Group Targets Consumer Education Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO drugstore.com Expects to Reach Profitability Target in 2003 Human Genome Project Leads to Innovative Healthcare NPIcenter’s Career Center targets nutraceutical Industry Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Editorial: An Exercise in Synergy NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway Natural Health Trends Corp. Launches Lexxus Taiwan FDA Presents Compliance Guide for Structure/Function Claims New TrimFit® Bars Redefine Energy Bar Category New TrimFit® Bars Redefine Energy Bar Category Probiata® Offers Safe, Natural and Effective Alternative Alive & Well with Michelle Harris Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com Consumers Search for Healthy Cleaning Products That Work Nordic Naturals: Omega 3 Fatty Acids Cyanotech Names Bob Capelli as Director of Sales Lipid Nutrition Acquires PharmaNutrients’ CLA One Business Lipid Nutrition has signed an agreement to acquire PharmaNutrients’ CLA One® business effective February 1, 2006. Lipid Nutrition Acquires PharmaNutrients’ CLA One Business Lipid Nutrition has signed an agreement to acquire PharmaNutrients’ CLA One® business effective February 1, 2006. Neptune Technologies & Bioressources Inc. Reports Second Quarter Results Company reports operating revenues of $1,445,000 compared to $1,180,000, for the second quarter in 2005, with EBITDA increasing to $245,000 compared to $119,000 prior year. Neptune Technologies & Bioressources Inc. Reports Second Quarter Results Company reports operating revenues of $1,445,000 compared to $1,180,000, for the second quarter in 2005, with EBITDA increasing to $245,000 compared to $119,000 prior year. NBTY Reports First Quarter Results Company reports that net sales increased $35 million, or 8%, to $455 million (including $33 million in net sales due to the acquisition of Solgar, LeNaturiste and SISU) compared to sales of $420 million prior year, as net income was $23 million, or $0.33 per diluted share, compared to $30 million, or $0.43 per diluted share, for the fiscal first quarter ended December 31, 2004. NBTY Reports First Quarter Results Company reports that net sales increased $35 million, or 8%, to $455 million (including $33 million in net sales due to the acquisition of Solgar, LeNaturiste and SISU) compared to sales of $420 million prior year, as net income was $23 million, or $0.33 per diluted share, compared to $30 million, or $0.43 per diluted share, for the fiscal first quarter ended December 31, 2004. Zuellig Appoints George Pontiakos President and CEO of North American Operations Company announces the appointment of George M. Pontiakos to President and CEO of Zuellig Group North America, to oversee all aspects of North American operations including BI Nutraceuticals, Premium Performance Ingredients, AF Zeta and the Zuellig Group Nutrition and Ingredients, China. Zuellig Appoints George Pontiakos President and CEO of North American Operations Company announces the appointment of George M. Pontiakos to President and CEO of Zuellig Group North America, to oversee all aspects of North American operations including BI Nutraceuticals, Premium Performance Ingredients, AF Zeta and the Zuellig Group Nutrition and Ingredients, China. Zuellig Appoints George Pontiakos President and CEO of North American Operations Company announces the appointment of George M. Pontiakos to President and CEO of Zuellig Group North America, to oversee all aspects of North American operations including BI Nutraceuticals, Premium Performance Ingredients, AF Zeta and the Zuellig Group Nutrition and Ingredients, China. Zuellig Appoints George Pontiakos President and CEO of North American Operations Company announces the appointment of George M. Pontiakos to President and CEO of Zuellig Group North America, to oversee all aspects of North American operations including BI Nutraceuticals, Premium Performance Ingredients, AF Zeta and the Zuellig Group Nutrition and Ingredients, China. Zuellig Appoints George Pontiakos President and CEO of North American Operations Company announces the appointment of George M. Pontiakos to President and CEO of Zuellig Group North America, to oversee all aspects of North American operations including BI Nutraceuticals, Premium Performance Ingredients, AF Zeta and the Zuellig Group Nutrition and Ingredients, China. AMS Health Sciences, Inc. Announces Appointment of New President Company announces the appointment of Jerry W. Grizzle, PhD, as the Company President. AMS Health Sciences, Inc. Announces Appointment of New President Company announces the appointment of Jerry W. Grizzle, PhD, as the Company President. AMS Health Sciences, Inc. Announces Appointment of New President Company announces the appointment of Jerry W. Grizzle, PhD, as the Company President. AMS Health Sciences, Inc. Announces Appointment of New President Company announces the appointment of Jerry W. Grizzle, PhD, as the Company President. United Natural Foods, Inc. Names Randle E. Lindberg President of the Western Region Company has appointed Randle E. "Randy" Lindberg, the former President and Chief Executive Officer of Nature's Best, to the position of President of the Western Region. United Natural Foods, Inc. Names Randle E. Lindberg President of the Western Region Company has appointed Randle E. "Randy" Lindberg, the former President and Chief Executive Officer of Nature's Best, to the position of President of the Western Region. United Natural Foods, Inc. Names Randle E. Lindberg President of the Western Region Company has appointed Randle E. "Randy" Lindberg, the former President and Chief Executive Officer of Nature's Best, to the position of President of the Western Region. United Natural Foods, Inc. Names Randle E. Lindberg President of the Western Region Company has appointed Randle E. "Randy" Lindberg, the former President and Chief Executive Officer of Nature's Best, to the position of President of the Western Region. Leiner Health Products Reports Third Quarter 2006 Results Company reports net sales of $181.2 million compared to $189.3 million for the same period in fiscal 2005 with net income of $1.5 million for the quarter, compared to net income of $8.1 million for the same quarter prior year. Company notes improvement over the first two quarters resulted from stabilization of joint care margins on lower raw material costs and better fixed cost absorption from better plant throughput. Leiner Health Products Reports Third Quarter 2006 Results Company reports net sales of $181.2 million compared to $189.3 million for the same period in fiscal 2005 with net income of $1.5 million for the quarter, compared to net income of $8.1 million for the same quarter prior year. Company notes improvement over the first two quarters resulted from stabilization of joint care margins on lower raw material costs and better fixed cost absorption from better plant throughput. Stagnito Communications, FMI Announce Marketing Agreement Stagnito Communications Inc. announces a marketing agreement with the Food Marketing Institute in which it will produce a custom magazine for the Private Label Pavilion at the FMI Show, May 7-9 in Chicago. Stagnito Communications, FMI Announce Marketing Agreement Stagnito Communications Inc. announces a marketing agreement with the Food Marketing Institute in which it will produce a custom magazine for the Private Label Pavilion at the FMI Show, May 7-9 in Chicago. Stagnito Communications, FMI Announce Marketing Agreement Stagnito Communications Inc. announces a marketing agreement with the Food Marketing Institute in which it will produce a custom magazine for the Private Label Pavilion at the FMI Show, May 7-9 in Chicago. Stagnito Communications, FMI Announce Marketing Agreement Stagnito Communications Inc. announces a marketing agreement with the Food Marketing Institute in which it will produce a custom magazine for the Private Label Pavilion at the FMI Show, May 7-9 in Chicago. One World Nutrition Completes Private Placement Offering One World Nutrition Inc. announced the closing of its initial private placement offering, after raising $3 million at $1.50 per share of common stock sold. One World Nutrition Completes Private Placement Offering One World Nutrition Inc. announced the closing of its initial private placement offering, after raising $3 million at $1.50 per share of common stock sold. Atkins Nutritionals, Inc. Announces New Board of Directors Robert W. Carpenter, president of ARAMARK Healthcare - Food, Kevin S. Flannery, president and CEO of Whelan Financial Corporation, Tim Healy, former chairman and CEO of Ubiquity Brands, Inc and Hugh R. Rovit, principal in interim management at Masson & Company LLC join President Mark S. Rodriguez on the Board of Directors. Atkins Nutritionals, Inc. Announces New Board of Directors Robert W. Carpenter, president of ARAMARK Healthcare - Food, Kevin S. Flannery, president and CEO of Whelan Financial Corporation, Tim Healy, former chairman and CEO of Ubiquity Brands, Inc and Hugh R. Rovit, principal in interim management at Masson & Company LLC join President Mark S. Rodriguez on the Board of Directors. Atkins Nutritionals, Inc. Announces New Board of Directors Robert W. Carpenter, president of ARAMARK Healthcare - Food, Kevin S. Flannery, president and CEO of Whelan Financial Corporation, Tim Healy, former chairman and CEO of Ubiquity Brands, Inc and Hugh R. Rovit, principal in interim management at Masson & Company LLC join President Mark S. Rodriguez on the Board of Directors. Atkins Nutritionals, Inc. Announces New Board of Directors Robert W. Carpenter, president of ARAMARK Healthcare - Food, Kevin S. Flannery, president and CEO of Whelan Financial Corporation, Tim Healy, former chairman and CEO of Ubiquity Brands, Inc and Hugh R. Rovit, principal in interim management at Masson & Company LLC join President Mark S. Rodriguez on the Board of Directors. The Hain Celestial Group Announces Sales and Earnings Company reports quarterly sales of $186.2 million, a 10% increase over the prior year's $169.8 million, with net income of $12.7 million, compared to the prior year's $10.7 million. The Hain Celestial Group Announces Sales and Earnings Company reports quarterly sales of $186.2 million, a 10% increase over the prior year's $169.8 million, with net income of $12.7 million, compared to the prior year's $10.7 million. Nutrition 21 Retains Dresdner Kleinwort Wasserstein Company announces that it has retained the investment banking firm Dresdner Kleinwort Wasserstein to assist the company in evaluating possible strategic alternatives. Nutrition 21 Retains Dresdner Kleinwort Wasserstein Company announces that it has retained the investment banking firm Dresdner Kleinwort Wasserstein to assist the company in evaluating possible strategic alternatives. CV Technologies Conditionally Approved for Listing on the TSX CV Technologies will begin trading on the TSX under its current symbol, CVQ, at a date yet to be determined. CV Technologies Conditionally Approved for Listing on the TSX CV Technologies will begin trading on the TSX under its current symbol, CVQ, at a date yet to be determined. MidOcean Partners Agrees to Sell Majority Stake in Vitaquest International to CK Life Sciences MidOcean Partners has announced the signing of a definitive agreement to sell its majority stake in Vitaquest to an affiliate of CK Life Sciences Int'l., Inc., in a transaction that values Vitaquest at a total enterprise value of $345 million. MidOcean Partners Agrees to Sell Majority Stake in Vitaquest International to CK Life Sciences MidOcean Partners has announced the signing of a definitive agreement to sell its majority stake in Vitaquest to an affiliate of CK Life Sciences Int'l., Inc., in a transaction that values Vitaquest at a total enterprise value of $345 million. MidOcean Partners Agrees to Sell Majority Stake in Vitaquest International to CK Life Sciences MidOcean Partners has announced the signing of a definitive agreement to sell its majority stake in Vitaquest to an affiliate of CK Life Sciences Int'l., Inc., in a transaction that values Vitaquest at a total enterprise value of $345 million. Degussa Veteran to Lead Global Food Strategy at The Solae Company The Solae Company has announced that Thomas Damiano would lead the organization's global food platform strategy, resigning his position as Vice President of Commercial Development at Degussa AG's food ingredient business. Degussa Veteran to Lead Global Food Strategy at The Solae Company The Solae Company has announced that Thomas Damiano would lead the organization's global food platform strategy, resigning his position as Vice President of Commercial Development at Degussa AG's food ingredient business. Degussa Veteran to Lead Global Food Strategy at The Solae Company The Solae Company has announced that Thomas Damiano would lead the organization's global food platform strategy, resigning his position as Vice President of Commercial Development at Degussa AG's food ingredient business. Degussa Veteran to Lead Global Food Strategy at The Solae Company The Solae Company has announced that Thomas Damiano would lead the organization's global food platform strategy, resigning his position as Vice President of Commercial Development at Degussa AG's food ingredient business. Yasoo Health, Inc. Receives Nearly $1 Million to Develop Novel Nutritional Formulation Company received $936,375 in financing from the Cystic Fibrosis Foundation to develop and commercialize a formulation that addresses a key nutritional problem of poor fat-soluble vitamin and nutrient absorption in cystic fibrosis patients. Yasoo Health, Inc. Receives Nearly $1 Million to Develop Novel Nutritional Formulation Company received $936,375 in financing from the Cystic Fibrosis Foundation to develop and commercialize a formulation that addresses a key nutritional problem of poor fat-soluble vitamin and nutrient absorption in cystic fibrosis patients. Yasoo Health, Inc. Receives Nearly $1 Million to Develop Novel Nutritional Formulation Company received $936,375 in financing from the Cystic Fibrosis Foundation to develop and commercialize a formulation that addresses a key nutritional problem of poor fat-soluble vitamin and nutrient absorption in cystic fibrosis patients. Yasoo Health, Inc. Receives Nearly $1 Million to Develop Novel Nutritional Formulation Company received $936,375 in financing from the Cystic Fibrosis Foundation to develop and commercialize a formulation that addresses a key nutritional problem of poor fat-soluble vitamin and nutrient absorption in cystic fibrosis patients. Yasoo Health, Inc. Receives Nearly $1 Million to Develop Novel Nutritional Formulation Company received $936,375 in financing from the Cystic Fibrosis Foundation to develop and commercialize a formulation that addresses a key nutritional problem of poor fat-soluble vitamin and nutrient absorption in cystic fibrosis patients. Yasoo Health, Inc. Receives Nearly $1 Million to Develop Novel Nutritional Formulation Company received $936,375 in financing from the Cystic Fibrosis Foundation to develop and commercialize a formulation that addresses a key nutritional problem of poor fat-soluble vitamin and nutrient absorption in cystic fibrosis patients. Yasoo Health, Inc. Receives Nearly $1 Million to Develop Novel Nutritional Formulation Company received $936,375 in financing from the Cystic Fibrosis Foundation to develop and commercialize a formulation that addresses a key nutritional problem of poor fat-soluble vitamin and nutrient absorption in cystic fibrosis patients. CK Life Sciences Spends $1.3b (US$166 million) to Expand into US Nutraceutical Market CK Life Sciences Int’l., Inc. will acquire an 80% direct interest in Vitaquest at a purchase price of HK$1,291.5 million (US$166 million), subject to adjustment at closing. CK Life Sciences Spends $1.3b (US$166 million) to Expand into US Nutraceutical Market CK Life Sciences Int’l., Inc. will acquire an 80% direct interest in Vitaquest at a purchase price of HK$1,291.5 million (US$166 million), subject to adjustment at closing. CK Life Sciences Spends $1.3b (US$166 million) to Expand into US Nutraceutical Market CK Life Sciences Int’l., Inc. will acquire an 80% direct interest in Vitaquest at a purchase price of HK$1,291.5 million (US$166 million), subject to adjustment at closing. USANA Reports Fourth Quarter and Year Results Company reports FY05 Q4 net sales of $86.9 million, compared with $75.1 million in the fourth quarter of the prior year, with earnings from operations of $15.4 million, compared with $12.2 million, for FY04 Q4. USANA Reports Fourth Quarter and Year Results Company reports FY05 Q4 net sales of $86.9 million, compared with $75.1 million in the fourth quarter of the prior year, with earnings from operations of $15.4 million, compared with $12.2 million, for FY04 Q4. Nu Skin Enterprises Reports Year-End and Fourth-Quarter Results Company reports FY05 Q4 revenue of $290.7 million (a decline of 5% from prior year) with net income of $15.8 million, which yielded earnings per share of $0.22 compared to net income of $22.0 million and earnings per share of $0.31 for the fourth quarter of 2004. According to the company, a weaker Japanese yen contributed to a revenue decline in North Asia, revenues in North America were up sharply. Nu Skin Enterprises Reports Year-End and Fourth-Quarter Results Company reports FY05 Q4 revenue of $290.7 million (a decline of 5% from prior year) with net income of $15.8 million, which yielded earnings per share of $0.22 compared to net income of $22.0 million and earnings per share of $0.31 for the fourth quarter of 2004. According to the company, a weaker Japanese yen contributed to a revenue decline in North Asia, revenues in North America were up sharply. Dean Foods Company Reports Fourth Quarter and Full Year Results Company reports net sales of $2.7 billion for the quarter, up 4% over prior year, with adjusted net income of $78 million ($0.54 per share), compared to net icome of $84.8 million ($0.55 per share) for the same quarter prior year. Dean Foods Company Reports Fourth Quarter and Full Year Results Company reports net sales of $2.7 billion for the quarter, up 4% over prior year, with adjusted net income of $78 million ($0.54 per share), compared to net icome of $84.8 million ($0.55 per share) for the same quarter prior year. DSM invests in new Process Flavours plant based on new technology New facility, doubling the company's production capacity of process flavours, will be build on the existing fully-owned DSM nutrition production site in Xinghuo, Shanghai, China and will use semi-continuous technology developed in cooperation between DSM's technology engineers and food technologists. DSM invests in new Process Flavours plant based on new technology New facility, doubling the company's production capacity of process flavours, will be build on the existing fully-owned DSM nutrition production site in Xinghuo, Shanghai, China and will use semi-continuous technology developed in cooperation between DSM's technology engineers and food technologists. $10 million funding for Biolactis Company announces the completion of its Series A financing round led by Inventages Venture Capital Investments Inc., of $7.3 million CAD with provision for follow on capital ($1.4 million). $10 million funding for Biolactis Company announces the completion of its Series A financing round led by Inventages Venture Capital Investments Inc., of $7.3 million CAD with provision for follow on capital ($1.4 million). Cyanotech Reports Third-Quarter Fiscal 2006 Financial Results Company sales for FY06 Q3 were $2,333,000, compared to sales of $3,180,000 for the same period of the prior fiscal year, with a net loss of $294,000, or ($0.01) per diluted share, compared to net income of $326,000, or $0.02 per diluted share for the same quarter of the prior year. Cyanotech Reports Third-Quarter Fiscal 2006 Financial Results Company sales for FY06 Q3 were $2,333,000, compared to sales of $3,180,000 for the same period of the prior fiscal year, with a net loss of $294,000, or ($0.01) per diluted share, compared to net income of $326,000, or $0.02 per diluted share for the same quarter of the prior year. Whole Foods Market Reports First Quarter Results Company reports quarterly sales of $1.7 billion, up 22% over prior year, with net income up 26% to $58.3 million. Comparable store sales grew 13% over the quarter. Whole Foods Market Reports First Quarter Results Company reports quarterly sales of $1.7 billion, up 22% over prior year, with net income up 26% to $58.3 million. Comparable store sales grew 13% over the quarter. MGP Ingredients Announces Fiscal 2006 Second Quarter Results Company reports net income of $818,000, or $0.05 per common share for the quarter compared to net income of $1,354,000, or $0.08 per share, for the second quarter of fiscal 2005. Net sales were $75,671,000 versus $61,164,000 in the prior year period. MGP Ingredients Announces Fiscal 2006 Second Quarter Results Company reports net income of $818,000, or $0.05 per common share for the quarter compared to net income of $1,354,000, or $0.08 per share, for the second quarter of fiscal 2005. Net sales were $75,671,000 versus $61,164,000 in the prior year period. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Another Reason to Choose Healthy Lifestyle Habits Another Reason to Choose Healthy Lifestyle Habits	MATAWAN, NJ, Feb 03, 2006 (BUSINESS WIRE) -- PacificHealth Laboratories, Inc. (PHLI), a leading nutrition technology company, announced that on Tuesday the U. S. Patent and Trademark Office issued patent number US 6,989,171 for the use of carbohydrate and protein in combination for a sports drink. Dr. Robert Portman, CEO of PHLI, said, "This new patent greatly strengthens our proprietary position for the Accelerade Sports Drink and the incorporation of this technology into related products such as a sports gel or bar. This patent is a powerful confirmation of the extensive scientific support demonstrating the superiority of Accelerade over conventional sports drinks." In the last two years studies from leading university exercise science labs have shown that Accelerade with its patented 4:1 ratio of carbohydrate to protein when compared to a conventional sports drink, improves endurance, reduces muscle damage and speeds muscle recovery after exercise. The most recent study has shown that Accelerade is 15% more effective in rehydrating athletes than the leading sports drink and 40% more effective than water. Based on these extraordinary results it is not surprising that Accelerade has found widespread acceptance and use by athletes in all sports at all levels from the weekend warrior to the professional. About PacificHealth Laboratories. Inc.: PacificHealth Laboratories, Inc., Matawan, NJ, was founded in 1995 to develop and commercialize functionally unique nutritional products for sports nutrition, weight loss and Type 2 diabetes. To learn more about PacificHealth Laboratories, Inc., visit www.pacifichealthlabs.com. Notice: This news release and oral statements made from time to time by Company representatives concerning the same subject matter may contain so-called "forward-looking statements". These statements can be identified by introductory words such as "expects", "plans", "will", "estimates", "forecasts", "projects" or words of similar meaning and by the fact they do not relate strictly to historical or current facts. Forward-looking statements frequently are used in discussing new products and their potential. Many factors may cause actual results to differ from forward-looking statements, including inaccurate assumptions and a broad variety of risks and uncertainties, some of which are known, such general economic conditions, consumer product acceptance and competitive products, and others of which are not. No forward-looking statements are a guarantee of future results or events, and one should avoid placing undue reliance on such statements.
Powered By Traffic Booster Absolute News Manager Plug-in by Xigla Software